Surgery Partners, Inc. Quarterly Operating Income (Loss) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Surgery Partners, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2014 to Q3 2024.
  • Surgery Partners, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $60.9M, a 26.3% decline year-over-year.
  • Surgery Partners, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $323M, a 0.72% increase year-over-year.
  • Surgery Partners, Inc. annual Operating Income (Loss) for 2023 was $328M, a 4.98% decline from 2022.
  • Surgery Partners, Inc. annual Operating Income (Loss) for 2022 was $345M, a 14.2% increase from 2021.
  • Surgery Partners, Inc. annual Operating Income (Loss) for 2021 was $302M, a 65.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $323M $60.9M -$21.7M -26.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $345M $84.8M -$12.8M -13.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $358M $76M +$29.6M +63.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $328M $101M +$7.2M +7.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $321M $82.6M +$8.5M +11.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $312M $97.6M +$21.1M +27.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $291M $46.4M -$54M -53.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $345M $94.2M -$20.6M -17.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $366M $74.1M +$10.5M +16.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $355M $76.5M +$17M +28.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $338M $100M +$36.1M +56.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $302M $115M +$18.5M +19.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $284M $63.6M +$45.1M +244% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $239M $59.5M +$14.8M +33.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $224M $64.3M +$40.8M +174% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $183M $96.3M +$24.5M +34.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $159M $18.5M -$40.5M -68.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $199M $44.7M -$10.8M -19.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $210M $23.5M -$26.1M -52.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $236M $71.8M +$124M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $112M $59M +$14M +31.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $98.2M $55.5M +$12M +27.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $86.2M $49.6M +$8.4M +20.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $77.8M -$51.9M -$144M -156% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-10
Q3 2018 $222M $45M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $43.5M +$5.76M +15.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $41.2M -$521K -1.25% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $92.3M +$23.9M +34.9% Sep 1, 2017 Dec 31, 2017 10-K 2020-03-13
Q2 2017 $191M $37.7M -$13.2M -25.9% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $204M $41.7M +$7.44M +21.7% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $196M $68.4M +$47.3M +224% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-10
Q3 2016 $149M $42.8M -$1.43M -3.22% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $151M $50.9M +$9.95M +24.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $141M $34.3M -$4.07M -10.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $145M $21.1M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 $44.3M +$24.6M +125% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $41M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $38.4M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q3 2014 $19.7M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.